Roche's Commitment to Mpox Response
Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) testing. The company confirms that its cobas MPXV test, as well as the LightMix research use only kits, detect the latest mpox virus variants. Additionally, Roche is actively working to enhance laboratory testing capacity for mpox worldwide.
Global Health Emergency Announcement
Roche announced that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for mpox, formerly known as monkeypox. Mpox, a viral disease that can spread easily between people and from infected animals, has been declared a Public Health Emergency of International Concern by the World Health Organization.
Partnerships to Combat Mpox
Globally, Roche is partnering with governments, healthcare providers, and organizations dedicated to combating the mpox outbreak. The company is actively working with its partners to enhance mpox laboratory capacity worldwide and provides training for laboratories across the African continent at the Roche Scientific Campus.
Development of Diagnostic Tests
“Our commitment to support the global response to mpox began in 2022 when we developed a suite of tests to enable global access to rapid and high-quality PCR testing,” said the CEO of Roche Diagnostics. “Diagnostics are essential in addressing emerging public health challenges like mpox, as they enable healthcare providers to identify infected patients, devise effective treatment strategies, and take appropriate actions.”
LightMix Modular Virus Kits
To detect the mpox virus, Roche developed three unique LightMix Modular Virus kits for use on several instruments including the LightCycler and cobas systems. These assays are designed to aid in following the epidemiologic spread of the virus.
About the Cobas MPXV Test
The cobas MPXV test, granted Emergency Use authorization, is an automated real-time PCR test for detecting the virus that causes mpox in human lesion swabs. Utilizing a dual-target approach ensures that the test remains effective even with potential mutations in the virus.
Understanding Mpox Virus
MPXV, first detected in laboratory monkeys, is assumed to be transmitted from wild animals to humans or between humans. Symptoms include fever, chills, headaches, muscle aches, and a painful rash that can evolve into fluid-filled bumps before eventually healing.
About Roche
Founded in 1896, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company focuses on delivering innovative medicines and diagnostics to improve the health of people globally.
Roche has also been recognized for its sustainability efforts, highlighting its dedication to healthcare access and partnerships around the world.
Contact Information
For further inquiries, reach out to Roche Global Media Relations at +41 61 688 8888 or via email at media.relations@roche.com.
Frequently Asked Questions
What is Roche's role in the mpox outbreak?
Roche is providing diagnostics and enhancing laboratory testing capacity to support global health efforts against the mpox outbreak.
What tests has Roche developed for mpox?
Roche has developed the cobas MPXV test and several LightMix Modular Virus kits for the detection of the mpox virus.
How does mpox spread?
Mpox spreads easily between people and can also be transmitted from infected animals to humans.
What are the symptoms of mpox?
Symptoms of mpox include fever, chills, headache, muscle aches, and a painful rash that develops into fluid-filled bumps.
How long has Roche been in operation?
Roche was founded in 1896 and has since become a leader in biotechnology and diagnostics.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/